nodes	percent_of_prediction	percent_of_DWPC	metapath
Bosutinib—P-Glycoprotein Inhibitors—Cyclosporine—rheumatoid arthritis	0.383	1	CiPCiCtD
Bosutinib—PTK2B—Leflunomide—rheumatoid arthritis	0.0981	0.805	CbGbCtD
Bosutinib—PRKCQ—rheumatoid arthritis	0.0826	0.262	CbGaD
Bosutinib—SYK—rheumatoid arthritis	0.0826	0.262	CbGaD
Bosutinib—IRAK1—rheumatoid arthritis	0.0626	0.199	CbGaD
Bosutinib—PTK2—rheumatoid arthritis	0.0533	0.169	CbGaD
Bosutinib—BLK—rheumatoid arthritis	0.0338	0.107	CbGaD
Bosutinib—ABCB1—Methylprednisolone—rheumatoid arthritis	0.00274	0.0224	CbGbCtD
Bosutinib—CYP3A4—Ergocalciferol—rheumatoid arthritis	0.00222	0.0182	CbGbCtD
Bosutinib—ABCB1—Betamethasone—rheumatoid arthritis	0.00178	0.0146	CbGbCtD
Bosutinib—ABCB1—Prednisolone—rheumatoid arthritis	0.00175	0.0144	CbGbCtD
Bosutinib—ABCB1—Hydrocortisone—rheumatoid arthritis	0.00166	0.0136	CbGbCtD
Bosutinib—ABCB1—Prednisone—rheumatoid arthritis	0.00166	0.0136	CbGbCtD
Bosutinib—CYP3A4—Methylprednisolone—rheumatoid arthritis	0.00164	0.0134	CbGbCtD
Bosutinib—ABCB1—Cyclosporine—rheumatoid arthritis	0.00157	0.0129	CbGbCtD
Bosutinib—CYP3A4—Triamcinolone—rheumatoid arthritis	0.00124	0.0102	CbGbCtD
Bosutinib—CYP3A4—Betamethasone—rheumatoid arthritis	0.00107	0.00874	CbGbCtD
Bosutinib—CYP3A4—Prednisolone—rheumatoid arthritis	0.00105	0.00862	CbGbCtD
Bosutinib—ABCB1—Dexamethasone—rheumatoid arthritis	0.00103	0.00849	CbGbCtD
Bosutinib—CYP3A4—Hydrocortisone—rheumatoid arthritis	0.000997	0.00818	CbGbCtD
Bosutinib—CYP3A4—Prednisone—rheumatoid arthritis	0.000993	0.00814	CbGbCtD
Bosutinib—CYP3A4—Cyclosporine—rheumatoid arthritis	0.000941	0.00772	CbGbCtD
Bosutinib—Gefitinib—IRAK1—rheumatoid arthritis	0.000844	0.493	CrCbGaD
Bosutinib—ABCB1—Methotrexate—rheumatoid arthritis	0.000831	0.00682	CbGbCtD
Bosutinib—CYP3A4—Dexamethasone—rheumatoid arthritis	0.00062	0.00508	CbGbCtD
Bosutinib—Vandetanib—BLK—rheumatoid arthritis	0.00048	0.28	CrCbGaD
Bosutinib—PHKG1—saliva-secreting gland—rheumatoid arthritis	0.000299	0.00738	CbGeAlD
Bosutinib—SIK2—connective tissue—rheumatoid arthritis	0.000296	0.00729	CbGeAlD
Bosutinib—FES—saliva-secreting gland—rheumatoid arthritis	0.000287	0.00707	CbGeAlD
Bosutinib—VRK2—saliva-secreting gland—rheumatoid arthritis	0.000287	0.00707	CbGeAlD
Bosutinib—SRMS—connective tissue—rheumatoid arthritis	0.000269	0.00663	CbGeAlD
Bosutinib—STK25—parotid gland—rheumatoid arthritis	0.000264	0.0065	CbGeAlD
Bosutinib—SYK—connective tissue—rheumatoid arthritis	0.000259	0.00637	CbGeAlD
Bosutinib—PLK2—parotid gland—rheumatoid arthritis	0.000256	0.00632	CbGeAlD
Bosutinib—CDK2—connective tissue—rheumatoid arthritis	0.000256	0.00631	CbGeAlD
Bosutinib—Vandetanib—VEGFA—rheumatoid arthritis	0.000255	0.149	CrCbGaD
Bosutinib—STK25—saliva-secreting gland—rheumatoid arthritis	0.000253	0.00623	CbGeAlD
Bosutinib—PLK2—saliva-secreting gland—rheumatoid arthritis	0.000246	0.00605	CbGeAlD
Bosutinib—PLK2—connective tissue—rheumatoid arthritis	0.000226	0.00556	CbGeAlD
Bosutinib—PRKCQ—lymphoid tissue—rheumatoid arthritis	0.000219	0.0054	CbGeAlD
Bosutinib—STK4—connective tissue—rheumatoid arthritis	0.000216	0.00532	CbGeAlD
Bosutinib—STK33—digestive system—rheumatoid arthritis	0.000214	0.00527	CbGeAlD
Bosutinib—FRK—lymphoid tissue—rheumatoid arthritis	0.000211	0.0052	CbGeAlD
Bosutinib—TLK1—tendon—rheumatoid arthritis	0.000209	0.00515	CbGeAlD
Bosutinib—ERBB4—saliva-secreting gland—rheumatoid arthritis	0.000207	0.00511	CbGeAlD
Bosutinib—PRKCQ—tendon—rheumatoid arthritis	0.000206	0.00508	CbGeAlD
Bosutinib—ALK—connective tissue—rheumatoid arthritis	0.000204	0.00503	CbGeAlD
Bosutinib—TYRO3—connective tissue—rheumatoid arthritis	0.000204	0.00503	CbGeAlD
Bosutinib—BLK—lymphoid tissue—rheumatoid arthritis	0.000203	0.00501	CbGeAlD
Bosutinib—CLK3—digestive system—rheumatoid arthritis	0.000203	0.00501	CbGeAlD
Bosutinib—LYN—connective tissue—rheumatoid arthritis	0.000203	0.005	CbGeAlD
Bosutinib—EPHB2—lymphoid tissue—rheumatoid arthritis	0.000201	0.00496	CbGeAlD
Bosutinib—BTK—connective tissue—rheumatoid arthritis	0.000199	0.0049	CbGeAlD
Bosutinib—EPHB2—digestive system—rheumatoid arthritis	0.000199	0.0049	CbGeAlD
Bosutinib—BCR—parotid gland—rheumatoid arthritis	0.000198	0.00489	CbGeAlD
Bosutinib—NUAK2—parotid gland—rheumatoid arthritis	0.000198	0.00489	CbGeAlD
Bosutinib—EPHB3—saliva-secreting gland—rheumatoid arthritis	0.000197	0.00486	CbGeAlD
Bosutinib—TXK—lymphoid tissue—rheumatoid arthritis	0.000195	0.0048	CbGeAlD
Bosutinib—SRMS—digestive system—rheumatoid arthritis	0.000194	0.00479	CbGeAlD
Bosutinib—CLK3—tendon—rheumatoid arthritis	0.000193	0.00477	CbGeAlD
Bosutinib—CSK—parotid gland—rheumatoid arthritis	0.000192	0.00473	CbGeAlD
Bosutinib—CSNK1A1—parotid gland—rheumatoid arthritis	0.000191	0.0047	CbGeAlD
Bosutinib—BCR—saliva-secreting gland—rheumatoid arthritis	0.00019	0.00469	CbGeAlD
Bosutinib—NUAK2—saliva-secreting gland—rheumatoid arthritis	0.00019	0.00469	CbGeAlD
Bosutinib—CLK1—parotid gland—rheumatoid arthritis	0.000189	0.00467	CbGeAlD
Bosutinib—SYK—lymphoid tissue—rheumatoid arthritis	0.000189	0.00466	CbGeAlD
Bosutinib—PHKG1—tendon—rheumatoid arthritis	0.000189	0.00466	CbGeAlD
Bosutinib—ROCK1—connective tissue—rheumatoid arthritis	0.000188	0.00464	CbGeAlD
Bosutinib—CDK2—lymphoid tissue—rheumatoid arthritis	0.000187	0.00462	CbGeAlD
Bosutinib—EIF2AK1—tendon—rheumatoid arthritis	0.000187	0.00461	CbGeAlD
Bosutinib—SYK—digestive system—rheumatoid arthritis	0.000187	0.0046	CbGeAlD
Bosutinib—STK26—lymphoid tissue—rheumatoid arthritis	0.000186	0.00457	CbGeAlD
Bosutinib—CDK2—digestive system—rheumatoid arthritis	0.000185	0.00456	CbGeAlD
Bosutinib—CSK—saliva-secreting gland—rheumatoid arthritis	0.000184	0.00453	CbGeAlD
Bosutinib—STK26—digestive system—rheumatoid arthritis	0.000183	0.00452	CbGeAlD
Bosutinib—BMPR2—connective tissue—rheumatoid arthritis	0.000183	0.0045	CbGeAlD
Bosutinib—CSNK1A1—saliva-secreting gland—rheumatoid arthritis	0.000182	0.0045	CbGeAlD
Bosutinib—CLK1—saliva-secreting gland—rheumatoid arthritis	0.000181	0.00447	CbGeAlD
Bosutinib—VRK2—tendon—rheumatoid arthritis	0.000181	0.00447	CbGeAlD
Bosutinib—FES—tendon—rheumatoid arthritis	0.000181	0.00447	CbGeAlD
Bosutinib—TNIK—tendon—rheumatoid arthritis	0.000178	0.00438	CbGeAlD
Bosutinib—SYK—tendon—rheumatoid arthritis	0.000178	0.00438	CbGeAlD
Bosutinib—CSNK1E—parotid gland—rheumatoid arthritis	0.000177	0.00435	CbGeAlD
Bosutinib—CDK2—tendon—rheumatoid arthritis	0.000176	0.00434	CbGeAlD
Bosutinib—MAP4K4—connective tissue—rheumatoid arthritis	0.000176	0.00434	CbGeAlD
Bosutinib—WEE1—digestive system—rheumatoid arthritis	0.000176	0.00433	CbGeAlD
Bosutinib—DMPK—digestive system—rheumatoid arthritis	0.000176	0.00433	CbGeAlD
Bosutinib—STK26—tendon—rheumatoid arthritis	0.000174	0.0043	CbGeAlD
Bosutinib—SIK1—parotid gland—rheumatoid arthritis	0.000174	0.00428	CbGeAlD
Bosutinib—IRAK4—parotid gland—rheumatoid arthritis	0.000174	0.00428	CbGeAlD
Bosutinib—ULK3—parotid gland—rheumatoid arthritis	0.00017	0.00419	CbGeAlD
Bosutinib—MAP2K1—connective tissue—rheumatoid arthritis	0.00017	0.00419	CbGeAlD
Bosutinib—STK25—lymphoid tissue—rheumatoid arthritis	0.00017	0.00418	CbGeAlD
Bosutinib—CSNK1E—saliva-secreting gland—rheumatoid arthritis	0.000169	0.00417	CbGeAlD
Bosutinib—CSK—connective tissue—rheumatoid arthritis	0.000169	0.00416	CbGeAlD
Bosutinib—CHEK2—tendon—rheumatoid arthritis	0.000168	0.00415	CbGeAlD
Bosutinib—STK25—digestive system—rheumatoid arthritis	0.000168	0.00413	CbGeAlD
Bosutinib—MAP3K7—parotid gland—rheumatoid arthritis	0.000167	0.00412	CbGeAlD
Bosutinib—WEE1—tendon—rheumatoid arthritis	0.000167	0.00412	CbGeAlD
Bosutinib—DMPK—tendon—rheumatoid arthritis	0.000167	0.00412	CbGeAlD
Bosutinib—CLK1—connective tissue—rheumatoid arthritis	0.000167	0.00411	CbGeAlD
Bosutinib—SIK1—saliva-secreting gland—rheumatoid arthritis	0.000166	0.0041	CbGeAlD
Bosutinib—IRAK4—saliva-secreting gland—rheumatoid arthritis	0.000166	0.0041	CbGeAlD
Bosutinib—TBK1—parotid gland—rheumatoid arthritis	0.000165	0.00407	CbGeAlD
Bosutinib—PLK2—lymphoid tissue—rheumatoid arthritis	0.000165	0.00407	CbGeAlD
Bosutinib—BMP2K—connective tissue—rheumatoid arthritis	0.000164	0.00403	CbGeAlD
Bosutinib—ERBB3—saliva-secreting gland—rheumatoid arthritis	0.000163	0.00402	CbGeAlD
Bosutinib—PLK2—digestive system—rheumatoid arthritis	0.000163	0.00402	CbGeAlD
Bosutinib—ULK3—saliva-secreting gland—rheumatoid arthritis	0.000163	0.00401	CbGeAlD
Bosutinib—MAP2K2—saliva-secreting gland—rheumatoid arthritis	0.000163	0.00401	CbGeAlD
Bosutinib—MAP3K7—saliva-secreting gland—rheumatoid arthritis	0.00016	0.00395	CbGeAlD
Bosutinib—STK25—tendon—rheumatoid arthritis	0.00016	0.00393	CbGeAlD
Bosutinib—RPS6KB1—parotid gland—rheumatoid arthritis	0.000159	0.00392	CbGeAlD
Bosutinib—PTK2—saliva-secreting gland—rheumatoid arthritis	0.000158	0.0039	CbGeAlD
Bosutinib—TBK1—saliva-secreting gland—rheumatoid arthritis	0.000158	0.0039	CbGeAlD
Bosutinib—PTK2B—connective tissue—rheumatoid arthritis	0.000158	0.00389	CbGeAlD
Bosutinib—STK4—lymphoid tissue—rheumatoid arthritis	0.000158	0.00389	CbGeAlD
Bosutinib—STK4—digestive system—rheumatoid arthritis	0.000156	0.00384	CbGeAlD
Bosutinib—PLK2—tendon—rheumatoid arthritis	0.000155	0.00382	CbGeAlD
Bosutinib—SIK3—tendon—rheumatoid arthritis	0.000154	0.0038	CbGeAlD
Bosutinib—SIK1—connective tissue—rheumatoid arthritis	0.000153	0.00377	CbGeAlD
Bosutinib—RPS6KB1—saliva-secreting gland—rheumatoid arthritis	0.000152	0.00375	CbGeAlD
Bosutinib—SLK—parotid gland—rheumatoid arthritis	0.000151	0.00373	CbGeAlD
Bosutinib—EPHB4—parotid gland—rheumatoid arthritis	0.00015	0.00371	CbGeAlD
Bosutinib—ERBB3—connective tissue—rheumatoid arthritis	0.00015	0.0037	CbGeAlD
Bosutinib—TYRO3—lymphoid tissue—rheumatoid arthritis	0.000149	0.00368	CbGeAlD
Bosutinib—ALK—lymphoid tissue—rheumatoid arthritis	0.000149	0.00368	CbGeAlD
Bosutinib—FER—lymphoid tissue—rheumatoid arthritis	0.000149	0.00368	CbGeAlD
Bosutinib—MAP3K2—connective tissue—rheumatoid arthritis	0.000148	0.00366	CbGeAlD
Bosutinib—LYN—lymphoid tissue—rheumatoid arthritis	0.000148	0.00366	CbGeAlD
Bosutinib—EPHA2—parotid gland—rheumatoid arthritis	0.000148	0.00364	CbGeAlD
Bosutinib—EPHA5—digestive system—rheumatoid arthritis	0.000147	0.00363	CbGeAlD
Bosutinib—ALK—digestive system—rheumatoid arthritis	0.000147	0.00363	CbGeAlD
Bosutinib—CAMK1D—tendon—rheumatoid arthritis	0.000147	0.00361	CbGeAlD
Bosutinib—MAP4K1—lymphoid tissue—rheumatoid arthritis	0.000146	0.0036	CbGeAlD
Bosutinib—PTK2—connective tissue—rheumatoid arthritis	0.000145	0.00359	CbGeAlD
Bosutinib—BTK—lymphoid tissue—rheumatoid arthritis	0.000145	0.00358	CbGeAlD
Bosutinib—SLK—saliva-secreting gland—rheumatoid arthritis	0.000145	0.00358	CbGeAlD
Bosutinib—STK24—tendon—rheumatoid arthritis	0.000145	0.00357	CbGeAlD
Bosutinib—EPHB4—saliva-secreting gland—rheumatoid arthritis	0.000144	0.00355	CbGeAlD
Bosutinib—MAP3K3—parotid gland—rheumatoid arthritis	0.000144	0.00355	CbGeAlD
Bosutinib—MAP4K5—parotid gland—rheumatoid arthritis	0.000144	0.00355	CbGeAlD
Bosutinib—EPHA2—saliva-secreting gland—rheumatoid arthritis	0.000141	0.00348	CbGeAlD
Bosutinib—MAP4K2—lymphoid tissue—rheumatoid arthritis	0.000141	0.00348	CbGeAlD
Bosutinib—FER—tendon—rheumatoid arthritis	0.00014	0.00346	CbGeAlD
Bosutinib—RPS6KB1—connective tissue—rheumatoid arthritis	0.00014	0.00345	CbGeAlD
Bosutinib—AXL—connective tissue—rheumatoid arthritis	0.000138	0.00341	CbGeAlD
Bosutinib—MAP3K3—saliva-secreting gland—rheumatoid arthritis	0.000138	0.0034	CbGeAlD
Bosutinib—MAP4K5—saliva-secreting gland—rheumatoid arthritis	0.000138	0.0034	CbGeAlD
Bosutinib—ROCK1—lymphoid tissue—rheumatoid arthritis	0.000138	0.00339	CbGeAlD
Bosutinib—MAP4K1—tendon—rheumatoid arthritis	0.000137	0.00339	CbGeAlD
Bosutinib—BTK—tendon—rheumatoid arthritis	0.000137	0.00337	CbGeAlD
Bosutinib—ROCK1—digestive system—rheumatoid arthritis	0.000136	0.00335	CbGeAlD
Bosutinib—BMPR2—lymphoid tissue—rheumatoid arthritis	0.000134	0.00329	CbGeAlD
Bosutinib—YES1—parotid gland—rheumatoid arthritis	0.000133	0.00328	CbGeAlD
Bosutinib—MAP4K2—tendon—rheumatoid arthritis	0.000133	0.00327	CbGeAlD
Bosutinib—EPHB4—connective tissue—rheumatoid arthritis	0.000132	0.00326	CbGeAlD
Bosutinib—BMPR2—digestive system—rheumatoid arthritis	0.000132	0.00325	CbGeAlD
Bosutinib—TAOK3—parotid gland—rheumatoid arthritis	0.000131	0.00323	CbGeAlD
Bosutinib—MERTK—lymphoid tissue—rheumatoid arthritis	0.000131	0.00323	CbGeAlD
Bosutinib—STK3—tendon—rheumatoid arthritis	0.000131	0.00323	CbGeAlD
Bosutinib—ERBB4—tendon—rheumatoid arthritis	0.000131	0.00323	CbGeAlD
Bosutinib—EPHB3—digestive system—rheumatoid arthritis	0.000131	0.00323	CbGeAlD
Bosutinib—FYN—connective tissue—rheumatoid arthritis	0.00013	0.0032	CbGeAlD
Bosutinib—MAP4K4—lymphoid tissue—rheumatoid arthritis	0.000129	0.00317	CbGeAlD
Bosutinib—BCR—lymphoid tissue—rheumatoid arthritis	0.000128	0.00315	CbGeAlD
Bosutinib—YES1—saliva-secreting gland—rheumatoid arthritis	0.000127	0.00314	CbGeAlD
Bosutinib—MAP4K4—digestive system—rheumatoid arthritis	0.000127	0.00313	CbGeAlD
Bosutinib—TAOK3—saliva-secreting gland—rheumatoid arthritis	0.000126	0.0031	CbGeAlD
Bosutinib—BMPR2—tendon—rheumatoid arthritis	0.000126	0.0031	CbGeAlD
Bosutinib—STK36—tendon—rheumatoid arthritis	0.000125	0.00307	CbGeAlD
Bosutinib—MAP2K1—lymphoid tissue—rheumatoid arthritis	0.000124	0.00306	CbGeAlD
Bosutinib—CSK—lymphoid tissue—rheumatoid arthritis	0.000123	0.00304	CbGeAlD
Bosutinib—MERTK—tendon—rheumatoid arthritis	0.000123	0.00304	CbGeAlD
Bosutinib—MAP2K1—digestive system—rheumatoid arthritis	0.000123	0.00302	CbGeAlD
Bosutinib—CSNK1A1—lymphoid tissue—rheumatoid arthritis	0.000123	0.00302	CbGeAlD
Bosutinib—CSK—digestive system—rheumatoid arthritis	0.000122	0.003	CbGeAlD
Bosutinib—HCK—lymphoid tissue—rheumatoid arthritis	0.000122	0.003	CbGeAlD
Bosutinib—CLK1—lymphoid tissue—rheumatoid arthritis	0.000122	0.003	CbGeAlD
Bosutinib—CSNK1A1—digestive system—rheumatoid arthritis	0.000121	0.00299	CbGeAlD
Bosutinib—MAP4K4—tendon—rheumatoid arthritis	0.000121	0.00298	CbGeAlD
Bosutinib—HCK—digestive system—rheumatoid arthritis	0.00012	0.00297	CbGeAlD
Bosutinib—CLK1—digestive system—rheumatoid arthritis	0.00012	0.00297	CbGeAlD
Bosutinib—BCR—tendon—rheumatoid arthritis	0.00012	0.00296	CbGeAlD
Bosutinib—MAP3K12—tendon—rheumatoid arthritis	0.000119	0.00294	CbGeAlD
Bosutinib—CAMK2G—digestive system—rheumatoid arthritis	0.000118	0.00291	CbGeAlD
Bosutinib—MAP2K5—parotid gland—rheumatoid arthritis	0.000118	0.0029	CbGeAlD
Bosutinib—YES1—connective tissue—rheumatoid arthritis	0.000117	0.00288	CbGeAlD
Bosutinib—STK35—tendon—rheumatoid arthritis	0.000117	0.00288	CbGeAlD
Bosutinib—CSK—tendon—rheumatoid arthritis	0.000116	0.00286	CbGeAlD
Bosutinib—PTK2B—lymphoid tissue—rheumatoid arthritis	0.000115	0.00285	CbGeAlD
Bosutinib—TAOK3—connective tissue—rheumatoid arthritis	0.000115	0.00285	CbGeAlD
Bosutinib—CSNK1A1—tendon—rheumatoid arthritis	0.000115	0.00284	CbGeAlD
Bosutinib—HCK—tendon—rheumatoid arthritis	0.000115	0.00282	CbGeAlD
Bosutinib—CLK1—tendon—rheumatoid arthritis	0.000115	0.00282	CbGeAlD
Bosutinib—PTK2B—digestive system—rheumatoid arthritis	0.000114	0.00281	CbGeAlD
Bosutinib—ABL2—tendon—rheumatoid arthritis	0.000114	0.00281	CbGeAlD
Bosutinib—MAP2K5—saliva-secreting gland—rheumatoid arthritis	0.000113	0.00278	CbGeAlD
Bosutinib—SRC—connective tissue—rheumatoid arthritis	0.000113	0.00277	CbGeAlD
Bosutinib—BMP2K—tendon—rheumatoid arthritis	0.000112	0.00277	CbGeAlD
Bosutinib—CAMK2G—tendon—rheumatoid arthritis	0.000112	0.00277	CbGeAlD
Bosutinib—CSNK1E—digestive system—rheumatoid arthritis	0.000112	0.00277	CbGeAlD
Bosutinib—SIK1—lymphoid tissue—rheumatoid arthritis	0.000112	0.00276	CbGeAlD
Bosutinib—IRAK4—lymphoid tissue—rheumatoid arthritis	0.000112	0.00276	CbGeAlD
Bosutinib—LRRK2—tendon—rheumatoid arthritis	0.000111	0.00275	CbGeAlD
Bosutinib—ERBB3—lymphoid tissue—rheumatoid arthritis	0.00011	0.0027	CbGeAlD
Bosutinib—MAP2K2—lymphoid tissue—rheumatoid arthritis	0.000109	0.0027	CbGeAlD
Bosutinib—MAP3K2—lymphoid tissue—rheumatoid arthritis	0.000109	0.00268	CbGeAlD
Bosutinib—PTK2B—tendon—rheumatoid arthritis	0.000109	0.00268	CbGeAlD
Bosutinib—ERBB3—digestive system—rheumatoid arthritis	0.000108	0.00267	CbGeAlD
Bosutinib—ULK3—digestive system—rheumatoid arthritis	0.000108	0.00266	CbGeAlD
Bosutinib—MAP2K2—digestive system—rheumatoid arthritis	0.000108	0.00266	CbGeAlD
Bosutinib—CSNK1E—tendon—rheumatoid arthritis	0.000107	0.00263	CbGeAlD
Bosutinib—PTK2—lymphoid tissue—rheumatoid arthritis	0.000106	0.00262	CbGeAlD
Bosutinib—TBK1—lymphoid tissue—rheumatoid arthritis	0.000106	0.00262	CbGeAlD
Bosutinib—SIK1—tendon—rheumatoid arthritis	0.000105	0.00259	CbGeAlD
Bosutinib—IRAK4—tendon—rheumatoid arthritis	0.000105	0.00259	CbGeAlD
Bosutinib—PTK2—digestive system—rheumatoid arthritis	0.000105	0.00259	CbGeAlD
Bosutinib—TBK1—digestive system—rheumatoid arthritis	0.000105	0.00259	CbGeAlD
Bosutinib—EPHA4—tendon—rheumatoid arthritis	0.000104	0.00257	CbGeAlD
Bosutinib—MAP2K2—tendon—rheumatoid arthritis	0.000103	0.00253	CbGeAlD
Bosutinib—ULK3—tendon—rheumatoid arthritis	0.000103	0.00253	CbGeAlD
Bosutinib—RPS6KB1—lymphoid tissue—rheumatoid arthritis	0.000102	0.00252	CbGeAlD
Bosutinib—PLK2—Levonorgestrel—Hydrocortisone—rheumatoid arthritis	0.000102	0.0823	CbGdCrCtD
Bosutinib—PDGFRB—parotid gland—rheumatoid arthritis	0.000102	0.00251	CbGeAlD
Bosutinib—FGR—lymphoid tissue—rheumatoid arthritis	0.000102	0.00251	CbGeAlD
Bosutinib—AXL—lymphoid tissue—rheumatoid arthritis	0.000101	0.0025	CbGeAlD
Bosutinib—MAP3K7—tendon—rheumatoid arthritis	0.000101	0.00249	CbGeAlD
Bosutinib—RPS6KB1—digestive system—rheumatoid arthritis	0.000101	0.00249	CbGeAlD
Bosutinib—CSF1R—connective tissue—rheumatoid arthritis	0.000101	0.00249	CbGeAlD
Bosutinib—FGR—digestive system—rheumatoid arthritis	0.0001	0.00248	CbGeAlD
Bosutinib—TBK1—tendon—rheumatoid arthritis	0.0001	0.00246	CbGeAlD
Bosutinib—PTK2—tendon—rheumatoid arthritis	0.0001	0.00246	CbGeAlD
Bosutinib—MAP4K4—Testosterone Propionate—Hydrocortisone—rheumatoid arthritis	9.81e-05	0.0793	CbGdCrCtD
Bosutinib—IRAK1—tendon—rheumatoid arthritis	9.8e-05	0.00242	CbGeAlD
Bosutinib—PDGFRB—saliva-secreting gland—rheumatoid arthritis	9.75e-05	0.0024	CbGeAlD
Bosutinib—RPS6KB1—tendon—rheumatoid arthritis	9.62e-05	0.00237	CbGeAlD
Bosutinib—EPHB4—digestive system—rheumatoid arthritis	9.56e-05	0.00236	CbGeAlD
Bosutinib—FGR—tendon—rheumatoid arthritis	9.56e-05	0.00236	CbGeAlD
Bosutinib—AXL—tendon—rheumatoid arthritis	9.52e-05	0.00235	CbGeAlD
Bosutinib—EPHA2—lymphoid tissue—rheumatoid arthritis	9.49e-05	0.00234	CbGeAlD
Bosutinib—FYN—lymphoid tissue—rheumatoid arthritis	9.48e-05	0.00234	CbGeAlD
Bosutinib—EPHA2—digestive system—rheumatoid arthritis	9.38e-05	0.00231	CbGeAlD
Bosutinib—FYN—digestive system—rheumatoid arthritis	9.36e-05	0.00231	CbGeAlD
Bosutinib—MAP4K5—lymphoid tissue—rheumatoid arthritis	9.26e-05	0.00228	CbGeAlD
Bosutinib—SLK—tendon—rheumatoid arthritis	9.16e-05	0.00226	CbGeAlD
Bosutinib—EPHB4—tendon—rheumatoid arthritis	9.1e-05	0.00224	CbGeAlD
Bosutinib—ABL1—parotid gland—rheumatoid arthritis	9.07e-05	0.00224	CbGeAlD
Bosutinib—PDGFRB—connective tissue—rheumatoid arthritis	8.96e-05	0.00221	CbGeAlD
Bosutinib—EPHA2—tendon—rheumatoid arthritis	8.92e-05	0.0022	CbGeAlD
Bosutinib—FYN—tendon—rheumatoid arthritis	8.91e-05	0.0022	CbGeAlD
Bosutinib—MAP3K3—tendon—rheumatoid arthritis	8.71e-05	0.00215	CbGeAlD
Bosutinib—MAP4K5—tendon—rheumatoid arthritis	8.71e-05	0.00215	CbGeAlD
Bosutinib—ABL1—saliva-secreting gland—rheumatoid arthritis	8.69e-05	0.00214	CbGeAlD
Bosutinib—YES1—lymphoid tissue—rheumatoid arthritis	8.55e-05	0.00211	CbGeAlD
Bosutinib—STK10—lymphoid tissue—rheumatoid arthritis	8.48e-05	0.00209	CbGeAlD
Bosutinib—YES1—digestive system—rheumatoid arthritis	8.45e-05	0.00208	CbGeAlD
Bosutinib—TAOK3—lymphoid tissue—rheumatoid arthritis	8.44e-05	0.00208	CbGeAlD
Bosutinib—STK10—digestive system—rheumatoid arthritis	8.37e-05	0.00206	CbGeAlD
Bosutinib—TAOK3—digestive system—rheumatoid arthritis	8.34e-05	0.00206	CbGeAlD
Bosutinib—SRC—lymphoid tissue—rheumatoid arthritis	8.23e-05	0.00203	CbGeAlD
Bosutinib—SRC—digestive system—rheumatoid arthritis	8.13e-05	0.002	CbGeAlD
Bosutinib—YES1—tendon—rheumatoid arthritis	8.04e-05	0.00198	CbGeAlD
Bosutinib—ABL1—connective tissue—rheumatoid arthritis	7.99e-05	0.00197	CbGeAlD
Bosutinib—STK10—tendon—rheumatoid arthritis	7.97e-05	0.00196	CbGeAlD
Bosutinib—TAOK3—tendon—rheumatoid arthritis	7.94e-05	0.00196	CbGeAlD
Bosutinib—EPHB2—Diflorasone—Methylprednisolone—rheumatoid arthritis	7.79e-05	0.063	CbGdCrCtD
Bosutinib—EPHB2—Diflorasone—Dexamethasone—rheumatoid arthritis	7.67e-05	0.062	CbGdCrCtD
Bosutinib—EPHB2—Diflorasone—Betamethasone—rheumatoid arthritis	7.67e-05	0.062	CbGdCrCtD
Bosutinib—EPHB2—Diflorasone—Triamcinolone—rheumatoid arthritis	7.49e-05	0.0606	CbGdCrCtD
Bosutinib—CSF1R—lymphoid tissue—rheumatoid arthritis	7.39e-05	0.00182	CbGeAlD
Bosutinib—CSF1R—digestive system—rheumatoid arthritis	7.3e-05	0.0018	CbGeAlD
Bosutinib—MAP2K5—tendon—rheumatoid arthritis	7.12e-05	0.00175	CbGeAlD
Bosutinib—EPHB2—Diflorasone—Prednisone—rheumatoid arthritis	7.11e-05	0.0575	CbGdCrCtD
Bosutinib—CSF1R—tendon—rheumatoid arthritis	6.94e-05	0.00171	CbGeAlD
Bosutinib—EPHB2—Diflorasone—Prednisolone—rheumatoid arthritis	6.94e-05	0.0561	CbGdCrCtD
Bosutinib—Vandetanib—ALB—rheumatoid arthritis	6.85e-05	0.04	CrCbGaD
Bosutinib—PDGFRB—lymphoid tissue—rheumatoid arthritis	6.55e-05	0.00162	CbGeAlD
Bosutinib—Gefitinib—ALB—rheumatoid arthritis	6.51e-05	0.038	CrCbGaD
Bosutinib—PDGFRB—digestive system—rheumatoid arthritis	6.47e-05	0.0016	CbGeAlD
Bosutinib—PDGFRB—tendon—rheumatoid arthritis	6.16e-05	0.00152	CbGeAlD
Bosutinib—ABL1—lymphoid tissue—rheumatoid arthritis	5.84e-05	0.00144	CbGeAlD
Bosutinib—ABL1—digestive system—rheumatoid arthritis	5.77e-05	0.00142	CbGeAlD
Bosutinib—ABL1—tendon—rheumatoid arthritis	5.49e-05	0.00135	CbGeAlD
Bosutinib—PKMYT1—Danazol—Hydrocortisone—rheumatoid arthritis	4.69e-05	0.0379	CbGdCrCtD
Bosutinib—Oedema—Prednisolone—rheumatoid arthritis	4.48e-05	0.00109	CcSEcCtD
Bosutinib—Neutropenia—Methotrexate—rheumatoid arthritis	4.47e-05	0.00109	CcSEcCtD
Bosutinib—CSNK1E—Danazol—Hydrocortisone—rheumatoid arthritis	4.47e-05	0.0361	CbGdCrCtD
Bosutinib—Dizziness—Azathioprine—rheumatoid arthritis	4.47e-05	0.00109	CcSEcCtD
Bosutinib—Upper respiratory tract infection—Methotrexate—rheumatoid arthritis	4.45e-05	0.00108	CcSEcCtD
Bosutinib—Cough—Triamcinolone—rheumatoid arthritis	4.4e-05	0.00107	CcSEcCtD
Bosutinib—Dyspnoea—Cyclosporine—rheumatoid arthritis	4.39e-05	0.00107	CcSEcCtD
Bosutinib—Oedema—Hydrocortisone—rheumatoid arthritis	4.37e-05	0.00106	CcSEcCtD
Bosutinib—Anaphylactic shock—Hydrocortisone—rheumatoid arthritis	4.37e-05	0.00106	CcSEcCtD
Bosutinib—Diarrhoea—Leflunomide—rheumatoid arthritis	4.36e-05	0.00106	CcSEcCtD
Bosutinib—Infection—Hydrocortisone—rheumatoid arthritis	4.35e-05	0.00106	CcSEcCtD
Bosutinib—Myalgia—Triamcinolone—rheumatoid arthritis	4.3e-05	0.00105	CcSEcCtD
Bosutinib—Vomiting—Azathioprine—rheumatoid arthritis	4.29e-05	0.00105	CcSEcCtD
Bosutinib—Nervous system disorder—Hydrocortisone—rheumatoid arthritis	4.29e-05	0.00104	CcSEcCtD
Bosutinib—Pneumonia—Methotrexate—rheumatoid arthritis	4.29e-05	0.00104	CcSEcCtD
Bosutinib—Arthralgia—Methylprednisolone—rheumatoid arthritis	4.29e-05	0.00104	CcSEcCtD
Bosutinib—Myalgia—Methylprednisolone—rheumatoid arthritis	4.29e-05	0.00104	CcSEcCtD
Bosutinib—Decreased appetite—Cyclosporine—rheumatoid arthritis	4.28e-05	0.00104	CcSEcCtD
Bosutinib—Infestation NOS—Methotrexate—rheumatoid arthritis	4.26e-05	0.00104	CcSEcCtD
Bosutinib—Infestation—Methotrexate—rheumatoid arthritis	4.26e-05	0.00104	CcSEcCtD
Bosutinib—Rash—Azathioprine—rheumatoid arthritis	4.26e-05	0.00104	CcSEcCtD
Bosutinib—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—rheumatoid arthritis	4.26e-05	0.00104	CcSEcCtD
Bosutinib—Dermatitis—Azathioprine—rheumatoid arthritis	4.25e-05	0.00104	CcSEcCtD
Bosutinib—Gastrointestinal disorder—Cyclosporine—rheumatoid arthritis	4.25e-05	0.00103	CcSEcCtD
Bosutinib—Skin disorder—Hydrocortisone—rheumatoid arthritis	4.25e-05	0.00103	CcSEcCtD
Bosutinib—Ill-defined disorder—Dexamethasone—rheumatoid arthritis	4.25e-05	0.00103	CcSEcCtD
Bosutinib—Ill-defined disorder—Betamethasone—rheumatoid arthritis	4.25e-05	0.00103	CcSEcCtD
Bosutinib—Discomfort—Triamcinolone—rheumatoid arthritis	4.25e-05	0.00103	CcSEcCtD
Bosutinib—Fatigue—Cyclosporine—rheumatoid arthritis	4.24e-05	0.00103	CcSEcCtD
Bosutinib—Discomfort—Methylprednisolone—rheumatoid arthritis	4.24e-05	0.00103	CcSEcCtD
Bosutinib—Headache—Azathioprine—rheumatoid arthritis	4.23e-05	0.00103	CcSEcCtD
Bosutinib—Dizziness—Leflunomide—rheumatoid arthritis	4.22e-05	0.00103	CcSEcCtD
Bosutinib—Pain—Cyclosporine—rheumatoid arthritis	4.21e-05	0.00102	CcSEcCtD
Bosutinib—Renal failure—Methotrexate—rheumatoid arthritis	4.19e-05	0.00102	CcSEcCtD
Bosutinib—Immune system disorder—Prednisone—rheumatoid arthritis	4.14e-05	0.00101	CcSEcCtD
Bosutinib—Malaise—Dexamethasone—rheumatoid arthritis	4.13e-05	0.00101	CcSEcCtD
Bosutinib—Malaise—Betamethasone—rheumatoid arthritis	4.13e-05	0.00101	CcSEcCtD
Bosutinib—Anaphylactic shock—Triamcinolone—rheumatoid arthritis	4.12e-05	0.001	CcSEcCtD
Bosutinib—Oedema—Triamcinolone—rheumatoid arthritis	4.12e-05	0.001	CcSEcCtD
Bosutinib—Anaphylactic shock—Methylprednisolone—rheumatoid arthritis	4.11e-05	0.001	CcSEcCtD
Bosutinib—Infection—Triamcinolone—rheumatoid arthritis	4.09e-05	0.000996	CcSEcCtD
Bosutinib—Infection—Methylprednisolone—rheumatoid arthritis	4.08e-05	0.000994	CcSEcCtD
Bosutinib—Feeling abnormal—Cyclosporine—rheumatoid arthritis	4.06e-05	0.000987	CcSEcCtD
Bosutinib—Vomiting—Leflunomide—rheumatoid arthritis	4.05e-05	0.000987	CcSEcCtD
Bosutinib—PKMYT1—Danazol—Prednisone—rheumatoid arthritis	4.04e-05	0.0326	CbGdCrCtD
Bosutinib—Hepatobiliary disease—Methotrexate—rheumatoid arthritis	4.03e-05	0.000982	CcSEcCtD
Bosutinib—Nervous system disorder—Methylprednisolone—rheumatoid arthritis	4.03e-05	0.000981	CcSEcCtD
Bosutinib—Gastrointestinal pain—Cyclosporine—rheumatoid arthritis	4.02e-05	0.00098	CcSEcCtD
Bosutinib—Rash—Leflunomide—rheumatoid arthritis	4.02e-05	0.000979	CcSEcCtD
Bosutinib—Dermatitis—Leflunomide—rheumatoid arthritis	4.02e-05	0.000978	CcSEcCtD
Bosutinib—Nausea—Azathioprine—rheumatoid arthritis	4.01e-05	0.000976	CcSEcCtD
Bosutinib—Headache—Leflunomide—rheumatoid arthritis	4e-05	0.000972	CcSEcCtD
Bosutinib—Skin disorder—Methylprednisolone—rheumatoid arthritis	3.99e-05	0.000972	CcSEcCtD
Bosutinib—Malnutrition—Prednisone—rheumatoid arthritis	3.99e-05	0.000971	CcSEcCtD
Bosutinib—Musculoskeletal discomfort—Hydrocortisone—rheumatoid arthritis	3.99e-05	0.00097	CcSEcCtD
Bosutinib—Agranulocytosis—Methotrexate—rheumatoid arthritis	3.98e-05	0.000969	CcSEcCtD
Bosutinib—Urticaria—Cyclosporine—rheumatoid arthritis	3.91e-05	0.000952	CcSEcCtD
Bosutinib—Myalgia—Betamethasone—rheumatoid arthritis	3.9e-05	0.000949	CcSEcCtD
Bosutinib—Myalgia—Dexamethasone—rheumatoid arthritis	3.9e-05	0.000949	CcSEcCtD
Bosutinib—Abdominal pain—Cyclosporine—rheumatoid arthritis	3.89e-05	0.000947	CcSEcCtD
Bosutinib—Body temperature increased—Cyclosporine—rheumatoid arthritis	3.89e-05	0.000947	CcSEcCtD
Bosutinib—Discomfort—Betamethasone—rheumatoid arthritis	3.85e-05	0.000937	CcSEcCtD
Bosutinib—Discomfort—Dexamethasone—rheumatoid arthritis	3.85e-05	0.000937	CcSEcCtD
Bosutinib—CSNK1E—Danazol—Prednisone—rheumatoid arthritis	3.85e-05	0.0311	CbGdCrCtD
Bosutinib—Pain—Prednisolone—rheumatoid arthritis	3.83e-05	0.000932	CcSEcCtD
Bosutinib—Hepatitis—Methotrexate—rheumatoid arthritis	3.83e-05	0.000932	CcSEcCtD
Bosutinib—Decreased appetite—Hydrocortisone—rheumatoid arthritis	3.8e-05	0.000925	CcSEcCtD
Bosutinib—Nausea—Leflunomide—rheumatoid arthritis	3.79e-05	0.000922	CcSEcCtD
Bosutinib—Urinary tract disorder—Methotrexate—rheumatoid arthritis	3.78e-05	0.00092	CcSEcCtD
Bosutinib—Gastrointestinal disorder—Hydrocortisone—rheumatoid arthritis	3.78e-05	0.000919	CcSEcCtD
Bosutinib—Fatigue—Hydrocortisone—rheumatoid arthritis	3.77e-05	0.000918	CcSEcCtD
Bosutinib—Urethral disorder—Methotrexate—rheumatoid arthritis	3.75e-05	0.000913	CcSEcCtD
Bosutinib—Musculoskeletal discomfort—Triamcinolone—rheumatoid arthritis	3.75e-05	0.000913	CcSEcCtD
Bosutinib—Musculoskeletal discomfort—Methylprednisolone—rheumatoid arthritis	3.74e-05	0.000911	CcSEcCtD
Bosutinib—Pain—Hydrocortisone—rheumatoid arthritis	3.74e-05	0.00091	CcSEcCtD
Bosutinib—Anaphylactic shock—Dexamethasone—rheumatoid arthritis	3.74e-05	0.00091	CcSEcCtD
Bosutinib—Anaphylactic shock—Betamethasone—rheumatoid arthritis	3.74e-05	0.00091	CcSEcCtD
Bosutinib—Oedema—Betamethasone—rheumatoid arthritis	3.74e-05	0.00091	CcSEcCtD
Bosutinib—Oedema—Dexamethasone—rheumatoid arthritis	3.74e-05	0.00091	CcSEcCtD
Bosutinib—Infection—Betamethasone—rheumatoid arthritis	3.71e-05	0.000904	CcSEcCtD
Bosutinib—Infection—Dexamethasone—rheumatoid arthritis	3.71e-05	0.000904	CcSEcCtD
Bosutinib—Ill-defined disorder—Prednisone—rheumatoid arthritis	3.7e-05	0.000901	CcSEcCtD
Bosutinib—Feeling abnormal—Prednisolone—rheumatoid arthritis	3.69e-05	0.000898	CcSEcCtD
Bosutinib—Anaemia—Prednisone—rheumatoid arthritis	3.69e-05	0.000897	CcSEcCtD
Bosutinib—Dyspnoea—Triamcinolone—rheumatoid arthritis	3.67e-05	0.000894	CcSEcCtD
Bosutinib—Nervous system disorder—Dexamethasone—rheumatoid arthritis	3.66e-05	0.000892	CcSEcCtD
Bosutinib—Nervous system disorder—Betamethasone—rheumatoid arthritis	3.66e-05	0.000892	CcSEcCtD
Bosutinib—Thrombocytopenia—Betamethasone—rheumatoid arthritis	3.66e-05	0.000891	CcSEcCtD
Bosutinib—Thrombocytopenia—Dexamethasone—rheumatoid arthritis	3.66e-05	0.000891	CcSEcCtD
Bosutinib—Erythema multiforme—Methotrexate—rheumatoid arthritis	3.62e-05	0.000881	CcSEcCtD
Bosutinib—Feeling abnormal—Hydrocortisone—rheumatoid arthritis	3.6e-05	0.000877	CcSEcCtD
Bosutinib—Malaise—Prednisone—rheumatoid arthritis	3.6e-05	0.000875	CcSEcCtD
Bosutinib—Gastrointestinal pain—Hydrocortisone—rheumatoid arthritis	3.58e-05	0.000871	CcSEcCtD
Bosutinib—Tinnitus—Methotrexate—rheumatoid arthritis	3.57e-05	0.000869	CcSEcCtD
Bosutinib—Urticaria—Prednisolone—rheumatoid arthritis	3.56e-05	0.000866	CcSEcCtD
Bosutinib—Cardiac disorder—Methotrexate—rheumatoid arthritis	3.55e-05	0.000865	CcSEcCtD
Bosutinib—Fatigue—Triamcinolone—rheumatoid arthritis	3.55e-05	0.000864	CcSEcCtD
Bosutinib—Fatigue—Methylprednisolone—rheumatoid arthritis	3.54e-05	0.000862	CcSEcCtD
Bosutinib—Asthenia—Cyclosporine—rheumatoid arthritis	3.53e-05	0.00086	CcSEcCtD
Bosutinib—Pain—Triamcinolone—rheumatoid arthritis	3.52e-05	0.000857	CcSEcCtD
Bosutinib—Pruritus—Cyclosporine—rheumatoid arthritis	3.48e-05	0.000848	CcSEcCtD
Bosutinib—Urticaria—Hydrocortisone—rheumatoid arthritis	3.47e-05	0.000846	CcSEcCtD
Bosutinib—Immune system disorder—Methotrexate—rheumatoid arthritis	3.46e-05	0.000842	CcSEcCtD
Bosutinib—Body temperature increased—Hydrocortisone—rheumatoid arthritis	3.46e-05	0.000842	CcSEcCtD
Bosutinib—Abdominal pain—Hydrocortisone—rheumatoid arthritis	3.46e-05	0.000842	CcSEcCtD
Bosutinib—Mediastinal disorder—Methotrexate—rheumatoid arthritis	3.45e-05	0.00084	CcSEcCtD
Bosutinib—Musculoskeletal discomfort—Betamethasone—rheumatoid arthritis	3.4e-05	0.000829	CcSEcCtD
Bosutinib—Musculoskeletal discomfort—Dexamethasone—rheumatoid arthritis	3.4e-05	0.000829	CcSEcCtD
Bosutinib—Myalgia—Prednisone—rheumatoid arthritis	3.4e-05	0.000826	CcSEcCtD
Bosutinib—Arthralgia—Prednisone—rheumatoid arthritis	3.4e-05	0.000826	CcSEcCtD
Bosutinib—Feeling abnormal—Triamcinolone—rheumatoid arthritis	3.39e-05	0.000826	CcSEcCtD
Bosutinib—Feeling abnormal—Methylprednisolone—rheumatoid arthritis	3.39e-05	0.000824	CcSEcCtD
Bosutinib—Unspecified disorder of skin and subcutaneous tissue—Prednisone—rheumatoid arthritis	3.37e-05	0.000821	CcSEcCtD
Bosutinib—Diarrhoea—Cyclosporine—rheumatoid arthritis	3.37e-05	0.00082	CcSEcCtD
Bosutinib—Gastrointestinal pain—Methylprednisolone—rheumatoid arthritis	3.36e-05	0.000818	CcSEcCtD
Bosutinib—Discomfort—Prednisone—rheumatoid arthritis	3.35e-05	0.000816	CcSEcCtD
Bosutinib—Malnutrition—Methotrexate—rheumatoid arthritis	3.33e-05	0.000811	CcSEcCtD
Bosutinib—Urticaria—Triamcinolone—rheumatoid arthritis	3.27e-05	0.000796	CcSEcCtD
Bosutinib—Urticaria—Methylprednisolone—rheumatoid arthritis	3.26e-05	0.000795	CcSEcCtD
Bosutinib—Dysgeusia—Methotrexate—rheumatoid arthritis	3.26e-05	0.000794	CcSEcCtD
Bosutinib—Body temperature increased—Triamcinolone—rheumatoid arthritis	3.26e-05	0.000792	CcSEcCtD
Bosutinib—Dizziness—Cyclosporine—rheumatoid arthritis	3.25e-05	0.000792	CcSEcCtD
Bosutinib—Oedema—Prednisone—rheumatoid arthritis	3.25e-05	0.000792	CcSEcCtD
Bosutinib—Anaphylactic shock—Prednisone—rheumatoid arthritis	3.25e-05	0.000792	CcSEcCtD
Bosutinib—Abdominal pain—Methylprednisolone—rheumatoid arthritis	3.25e-05	0.000791	CcSEcCtD
Bosutinib—Decreased appetite—Dexamethasone—rheumatoid arthritis	3.25e-05	0.000791	CcSEcCtD
Bosutinib—Decreased appetite—Betamethasone—rheumatoid arthritis	3.25e-05	0.000791	CcSEcCtD
Bosutinib—Infection—Prednisone—rheumatoid arthritis	3.23e-05	0.000787	CcSEcCtD
Bosutinib—Gastrointestinal disorder—Dexamethasone—rheumatoid arthritis	3.23e-05	0.000785	CcSEcCtD
Bosutinib—Gastrointestinal disorder—Betamethasone—rheumatoid arthritis	3.23e-05	0.000785	CcSEcCtD
Bosutinib—Back pain—Methotrexate—rheumatoid arthritis	3.22e-05	0.000785	CcSEcCtD
Bosutinib—Fatigue—Dexamethasone—rheumatoid arthritis	3.22e-05	0.000784	CcSEcCtD
Bosutinib—Fatigue—Betamethasone—rheumatoid arthritis	3.22e-05	0.000784	CcSEcCtD
Bosutinib—Pain—Betamethasone—rheumatoid arthritis	3.2e-05	0.000778	CcSEcCtD
Bosutinib—Pain—Dexamethasone—rheumatoid arthritis	3.2e-05	0.000778	CcSEcCtD
Bosutinib—Nervous system disorder—Prednisone—rheumatoid arthritis	3.19e-05	0.000777	CcSEcCtD
Bosutinib—Skin disorder—Prednisone—rheumatoid arthritis	3.16e-05	0.000769	CcSEcCtD
Bosutinib—Asthenia—Hydrocortisone—rheumatoid arthritis	3.14e-05	0.000764	CcSEcCtD
Bosutinib—Vomiting—Cyclosporine—rheumatoid arthritis	3.13e-05	0.000762	CcSEcCtD
Bosutinib—Rash—Cyclosporine—rheumatoid arthritis	3.1e-05	0.000755	CcSEcCtD
Bosutinib—Dermatitis—Cyclosporine—rheumatoid arthritis	3.1e-05	0.000755	CcSEcCtD
Bosutinib—Pruritus—Hydrocortisone—rheumatoid arthritis	3.09e-05	0.000753	CcSEcCtD
Bosutinib—Ill-defined disorder—Methotrexate—rheumatoid arthritis	3.09e-05	0.000753	CcSEcCtD
Bosutinib—Headache—Cyclosporine—rheumatoid arthritis	3.08e-05	0.00075	CcSEcCtD
Bosutinib—Anaemia—Methotrexate—rheumatoid arthritis	3.08e-05	0.00075	CcSEcCtD
Bosutinib—Feeling abnormal—Betamethasone—rheumatoid arthritis	3.08e-05	0.00075	CcSEcCtD
Bosutinib—Feeling abnormal—Dexamethasone—rheumatoid arthritis	3.08e-05	0.00075	CcSEcCtD
Bosutinib—Gastrointestinal pain—Dexamethasone—rheumatoid arthritis	3.06e-05	0.000744	CcSEcCtD
Bosutinib—Gastrointestinal pain—Betamethasone—rheumatoid arthritis	3.06e-05	0.000744	CcSEcCtD
Bosutinib—Malaise—Methotrexate—rheumatoid arthritis	3.01e-05	0.000731	CcSEcCtD
Bosutinib—Diarrhoea—Hydrocortisone—rheumatoid arthritis	2.99e-05	0.000728	CcSEcCtD
Bosutinib—Leukopenia—Methotrexate—rheumatoid arthritis	2.98e-05	0.000726	CcSEcCtD
Bosutinib—Urticaria—Betamethasone—rheumatoid arthritis	2.97e-05	0.000723	CcSEcCtD
Bosutinib—Urticaria—Dexamethasone—rheumatoid arthritis	2.97e-05	0.000723	CcSEcCtD
Bosutinib—Musculoskeletal discomfort—Prednisone—rheumatoid arthritis	2.97e-05	0.000722	CcSEcCtD
Bosutinib—Dizziness—Prednisolone—rheumatoid arthritis	2.96e-05	0.000721	CcSEcCtD
Bosutinib—Asthenia—Triamcinolone—rheumatoid arthritis	2.96e-05	0.000719	CcSEcCtD
Bosutinib—Abdominal pain—Dexamethasone—rheumatoid arthritis	2.95e-05	0.000719	CcSEcCtD
Bosutinib—Body temperature increased—Betamethasone—rheumatoid arthritis	2.95e-05	0.000719	CcSEcCtD
Bosutinib—Abdominal pain—Betamethasone—rheumatoid arthritis	2.95e-05	0.000719	CcSEcCtD
Bosutinib—Body temperature increased—Dexamethasone—rheumatoid arthritis	2.95e-05	0.000719	CcSEcCtD
Bosutinib—Asthenia—Methylprednisolone—rheumatoid arthritis	2.95e-05	0.000718	CcSEcCtD
Bosutinib—Nausea—Cyclosporine—rheumatoid arthritis	2.92e-05	0.000712	CcSEcCtD
Bosutinib—Pruritus—Triamcinolone—rheumatoid arthritis	2.91e-05	0.000709	CcSEcCtD
Bosutinib—Cough—Methotrexate—rheumatoid arthritis	2.91e-05	0.000708	CcSEcCtD
Bosutinib—Pruritus—Methylprednisolone—rheumatoid arthritis	2.91e-05	0.000708	CcSEcCtD
Bosutinib—Dizziness—Hydrocortisone—rheumatoid arthritis	2.89e-05	0.000704	CcSEcCtD
Bosutinib—CSNK1E—Dexamethasone—Hydrocortisone—rheumatoid arthritis	2.85e-05	0.0231	CbGdCrCtD
Bosutinib—CSNK1E—Betamethasone—Hydrocortisone—rheumatoid arthritis	2.85e-05	0.0231	CbGdCrCtD
Bosutinib—Myalgia—Methotrexate—rheumatoid arthritis	2.84e-05	0.000691	CcSEcCtD
Bosutinib—Chest pain—Methotrexate—rheumatoid arthritis	2.84e-05	0.000691	CcSEcCtD
Bosutinib—Arthralgia—Methotrexate—rheumatoid arthritis	2.84e-05	0.000691	CcSEcCtD
Bosutinib—Decreased appetite—Prednisone—rheumatoid arthritis	2.83e-05	0.000689	CcSEcCtD
Bosutinib—Rash—Prednisolone—rheumatoid arthritis	2.82e-05	0.000687	CcSEcCtD
Bosutinib—Dermatitis—Prednisolone—rheumatoid arthritis	2.82e-05	0.000687	CcSEcCtD
Bosutinib—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—rheumatoid arthritis	2.82e-05	0.000686	CcSEcCtD
Bosutinib—Diarrhoea—Methylprednisolone—rheumatoid arthritis	2.81e-05	0.000684	CcSEcCtD
Bosutinib—Fatigue—Prednisone—rheumatoid arthritis	2.81e-05	0.000683	CcSEcCtD
Bosutinib—Headache—Prednisolone—rheumatoid arthritis	2.81e-05	0.000683	CcSEcCtD
Bosutinib—Discomfort—Methotrexate—rheumatoid arthritis	2.8e-05	0.000682	CcSEcCtD
Bosutinib—Vomiting—Hydrocortisone—rheumatoid arthritis	2.78e-05	0.000677	CcSEcCtD
Bosutinib—Rash—Hydrocortisone—rheumatoid arthritis	2.76e-05	0.000671	CcSEcCtD
Bosutinib—Dermatitis—Hydrocortisone—rheumatoid arthritis	2.76e-05	0.000671	CcSEcCtD
Bosutinib—CHEK2—Testosterone Propionate—Hydrocortisone—rheumatoid arthritis	2.75e-05	0.0223	CbGdCrCtD
Bosutinib—Headache—Hydrocortisone—rheumatoid arthritis	2.74e-05	0.000667	CcSEcCtD
Bosutinib—Dizziness—Triamcinolone—rheumatoid arthritis	2.72e-05	0.000663	CcSEcCtD
Bosutinib—Anaphylactic shock—Methotrexate—rheumatoid arthritis	2.72e-05	0.000662	CcSEcCtD
Bosutinib—Dizziness—Methylprednisolone—rheumatoid arthritis	2.72e-05	0.000661	CcSEcCtD
Bosutinib—Infection—Methotrexate—rheumatoid arthritis	2.7e-05	0.000658	CcSEcCtD
Bosutinib—CSNK1E—Dexamethasone—Methylprednisolone—rheumatoid arthritis	2.69e-05	0.0218	CbGdCrCtD
Bosutinib—CSNK1E—Betamethasone—Methylprednisolone—rheumatoid arthritis	2.69e-05	0.0218	CbGdCrCtD
Bosutinib—Feeling abnormal—Prednisone—rheumatoid arthritis	2.68e-05	0.000653	CcSEcCtD
Bosutinib—Asthenia—Dexamethasone—rheumatoid arthritis	2.68e-05	0.000653	CcSEcCtD
Bosutinib—Asthenia—Betamethasone—rheumatoid arthritis	2.68e-05	0.000653	CcSEcCtD
Bosutinib—Nervous system disorder—Methotrexate—rheumatoid arthritis	2.67e-05	0.000649	CcSEcCtD
Bosutinib—Thrombocytopenia—Methotrexate—rheumatoid arthritis	2.66e-05	0.000648	CcSEcCtD
Bosutinib—Gastrointestinal pain—Prednisone—rheumatoid arthritis	2.66e-05	0.000648	CcSEcCtD
Bosutinib—Nausea—Prednisolone—rheumatoid arthritis	2.66e-05	0.000648	CcSEcCtD
Bosutinib—CSNK1E—Dexamethasone—Betamethasone—rheumatoid arthritis	2.65e-05	0.0214	CbGdCrCtD
Bosutinib—CSNK1E—Betamethasone—Dexamethasone—rheumatoid arthritis	2.65e-05	0.0214	CbGdCrCtD
Bosutinib—Pruritus—Dexamethasone—rheumatoid arthritis	2.64e-05	0.000644	CcSEcCtD
Bosutinib—Pruritus—Betamethasone—rheumatoid arthritis	2.64e-05	0.000644	CcSEcCtD
Bosutinib—Skin disorder—Methotrexate—rheumatoid arthritis	2.64e-05	0.000643	CcSEcCtD
Bosutinib—Vomiting—Triamcinolone—rheumatoid arthritis	2.62e-05	0.000637	CcSEcCtD
Bosutinib—Vomiting—Methylprednisolone—rheumatoid arthritis	2.61e-05	0.000636	CcSEcCtD
Bosutinib—Nausea—Hydrocortisone—rheumatoid arthritis	2.6e-05	0.000632	CcSEcCtD
Bosutinib—Rash—Triamcinolone—rheumatoid arthritis	2.6e-05	0.000632	CcSEcCtD
Bosutinib—Dermatitis—Triamcinolone—rheumatoid arthritis	2.59e-05	0.000631	CcSEcCtD
Bosutinib—Rash—Methylprednisolone—rheumatoid arthritis	2.59e-05	0.000631	CcSEcCtD
Bosutinib—CSNK1E—Dexamethasone—Triamcinolone—rheumatoid arthritis	2.59e-05	0.0209	CbGdCrCtD
Bosutinib—CSNK1E—Betamethasone—Triamcinolone—rheumatoid arthritis	2.59e-05	0.0209	CbGdCrCtD
Bosutinib—Dermatitis—Methylprednisolone—rheumatoid arthritis	2.59e-05	0.00063	CcSEcCtD
Bosutinib—Urticaria—Prednisone—rheumatoid arthritis	2.59e-05	0.000629	CcSEcCtD
Bosutinib—Headache—Triamcinolone—rheumatoid arthritis	2.58e-05	0.000628	CcSEcCtD
Bosutinib—Headache—Methylprednisolone—rheumatoid arthritis	2.57e-05	0.000627	CcSEcCtD
Bosutinib—Abdominal pain—Prednisone—rheumatoid arthritis	2.57e-05	0.000626	CcSEcCtD
Bosutinib—Body temperature increased—Prednisone—rheumatoid arthritis	2.57e-05	0.000626	CcSEcCtD
Bosutinib—Diarrhoea—Betamethasone—rheumatoid arthritis	2.56e-05	0.000622	CcSEcCtD
Bosutinib—Diarrhoea—Dexamethasone—rheumatoid arthritis	2.56e-05	0.000622	CcSEcCtD
Bosutinib—CYP3A4—digestive system—rheumatoid arthritis	2.53e-05	0.000625	CbGeAlD
Bosutinib—Musculoskeletal discomfort—Methotrexate—rheumatoid arthritis	2.48e-05	0.000603	CcSEcCtD
Bosutinib—Dizziness—Betamethasone—rheumatoid arthritis	2.47e-05	0.000601	CcSEcCtD
Bosutinib—Dizziness—Dexamethasone—rheumatoid arthritis	2.47e-05	0.000601	CcSEcCtD
Bosutinib—CSNK1E—Betamethasone—Prednisone—rheumatoid arthritis	2.46e-05	0.0199	CbGdCrCtD
Bosutinib—CSNK1E—Dexamethasone—Prednisone—rheumatoid arthritis	2.46e-05	0.0199	CbGdCrCtD
Bosutinib—Nausea—Triamcinolone—rheumatoid arthritis	2.45e-05	0.000595	CcSEcCtD
Bosutinib—Nausea—Methylprednisolone—rheumatoid arthritis	2.44e-05	0.000594	CcSEcCtD
Bosutinib—Dyspnoea—Methotrexate—rheumatoid arthritis	2.42e-05	0.00059	CcSEcCtD
Bosutinib—CSNK1E—Dexamethasone—Prednisolone—rheumatoid arthritis	2.4e-05	0.0194	CbGdCrCtD
Bosutinib—CSNK1E—Betamethasone—Prednisolone—rheumatoid arthritis	2.4e-05	0.0194	CbGdCrCtD
Bosutinib—Vomiting—Dexamethasone—rheumatoid arthritis	2.38e-05	0.000578	CcSEcCtD
Bosutinib—Vomiting—Betamethasone—rheumatoid arthritis	2.38e-05	0.000578	CcSEcCtD
Bosutinib—Decreased appetite—Methotrexate—rheumatoid arthritis	2.36e-05	0.000575	CcSEcCtD
Bosutinib—Rash—Betamethasone—rheumatoid arthritis	2.36e-05	0.000574	CcSEcCtD
Bosutinib—Rash—Dexamethasone—rheumatoid arthritis	2.36e-05	0.000574	CcSEcCtD
Bosutinib—Dermatitis—Dexamethasone—rheumatoid arthritis	2.35e-05	0.000573	CcSEcCtD
Bosutinib—Dermatitis—Betamethasone—rheumatoid arthritis	2.35e-05	0.000573	CcSEcCtD
Bosutinib—Gastrointestinal disorder—Methotrexate—rheumatoid arthritis	2.35e-05	0.000572	CcSEcCtD
Bosutinib—Fatigue—Methotrexate—rheumatoid arthritis	2.35e-05	0.000571	CcSEcCtD
Bosutinib—Headache—Dexamethasone—rheumatoid arthritis	2.34e-05	0.00057	CcSEcCtD
Bosutinib—Headache—Betamethasone—rheumatoid arthritis	2.34e-05	0.00057	CcSEcCtD
Bosutinib—Asthenia—Prednisone—rheumatoid arthritis	2.34e-05	0.000568	CcSEcCtD
Bosutinib—Pain—Methotrexate—rheumatoid arthritis	2.33e-05	0.000566	CcSEcCtD
Bosutinib—Pruritus—Prednisone—rheumatoid arthritis	2.3e-05	0.00056	CcSEcCtD
Bosutinib—CHEK2—Danazol—Hydrocortisone—rheumatoid arthritis	2.29e-05	0.0185	CbGdCrCtD
Bosutinib—Feeling abnormal—Methotrexate—rheumatoid arthritis	2.24e-05	0.000546	CcSEcCtD
Bosutinib—Diarrhoea—Prednisone—rheumatoid arthritis	2.23e-05	0.000542	CcSEcCtD
Bosutinib—Gastrointestinal pain—Methotrexate—rheumatoid arthritis	2.22e-05	0.000541	CcSEcCtD
Bosutinib—Nausea—Dexamethasone—rheumatoid arthritis	2.22e-05	0.00054	CcSEcCtD
Bosutinib—Nausea—Betamethasone—rheumatoid arthritis	2.22e-05	0.00054	CcSEcCtD
Bosutinib—Urticaria—Methotrexate—rheumatoid arthritis	2.16e-05	0.000526	CcSEcCtD
Bosutinib—Dizziness—Prednisone—rheumatoid arthritis	2.15e-05	0.000524	CcSEcCtD
Bosutinib—Abdominal pain—Methotrexate—rheumatoid arthritis	2.15e-05	0.000523	CcSEcCtD
Bosutinib—Body temperature increased—Methotrexate—rheumatoid arthritis	2.15e-05	0.000523	CcSEcCtD
Bosutinib—Vomiting—Prednisone—rheumatoid arthritis	2.07e-05	0.000504	CcSEcCtD
Bosutinib—CHEK2—Norethindrone—Hydrocortisone—rheumatoid arthritis	2.06e-05	0.0167	CbGdCrCtD
Bosutinib—Rash—Prednisone—rheumatoid arthritis	2.05e-05	0.000499	CcSEcCtD
Bosutinib—Dermatitis—Prednisone—rheumatoid arthritis	2.05e-05	0.000499	CcSEcCtD
Bosutinib—Headache—Prednisone—rheumatoid arthritis	2.04e-05	0.000496	CcSEcCtD
Bosutinib—CHEK2—Danazol—Prednisone—rheumatoid arthritis	1.97e-05	0.0159	CbGdCrCtD
Bosutinib—Asthenia—Methotrexate—rheumatoid arthritis	1.95e-05	0.000475	CcSEcCtD
Bosutinib—Nausea—Prednisone—rheumatoid arthritis	1.93e-05	0.000471	CcSEcCtD
Bosutinib—Pruritus—Methotrexate—rheumatoid arthritis	1.92e-05	0.000468	CcSEcCtD
Bosutinib—Diarrhoea—Methotrexate—rheumatoid arthritis	1.86e-05	0.000453	CcSEcCtD
Bosutinib—ABCB1—lymphoid tissue—rheumatoid arthritis	1.82e-05	0.000448	CbGeAlD
Bosutinib—Dizziness—Methotrexate—rheumatoid arthritis	1.8e-05	0.000438	CcSEcCtD
Bosutinib—ABCB1—digestive system—rheumatoid arthritis	1.79e-05	0.000442	CbGeAlD
Bosutinib—Vomiting—Methotrexate—rheumatoid arthritis	1.73e-05	0.000421	CcSEcCtD
Bosutinib—Rash—Methotrexate—rheumatoid arthritis	1.71e-05	0.000417	CcSEcCtD
Bosutinib—Dermatitis—Methotrexate—rheumatoid arthritis	1.71e-05	0.000417	CcSEcCtD
Bosutinib—Headache—Methotrexate—rheumatoid arthritis	1.7e-05	0.000415	CcSEcCtD
Bosutinib—CHEK2—Levonorgestrel—Hydrocortisone—rheumatoid arthritis	1.64e-05	0.0133	CbGdCrCtD
Bosutinib—Nausea—Methotrexate—rheumatoid arthritis	1.62e-05	0.000393	CcSEcCtD
Bosutinib—RPS6KB1—Signaling Pathways—VEGFA—rheumatoid arthritis	2.59e-07	2.72e-06	CbGpPWpGaD
Bosutinib—MAP2K5—Signaling Pathways—VEGFA—rheumatoid arthritis	2.59e-07	2.72e-06	CbGpPWpGaD
Bosutinib—YES1—Signaling Pathways—IL2—rheumatoid arthritis	2.58e-07	2.71e-06	CbGpPWpGaD
Bosutinib—EGFR—Signaling Pathways—LEP—rheumatoid arthritis	2.58e-07	2.71e-06	CbGpPWpGaD
Bosutinib—PTK2B—Signaling Pathways—TGFB1—rheumatoid arthritis	2.56e-07	2.69e-06	CbGpPWpGaD
Bosutinib—FYN—Signaling Pathways—POMC—rheumatoid arthritis	2.56e-07	2.69e-06	CbGpPWpGaD
Bosutinib—IRAK1—Signaling Pathways—CXCL8—rheumatoid arthritis	2.56e-07	2.69e-06	CbGpPWpGaD
Bosutinib—EGFR—Innate Immune System—IL6—rheumatoid arthritis	2.55e-07	2.68e-06	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling Pathways—POMC—rheumatoid arthritis	2.55e-07	2.68e-06	CbGpPWpGaD
Bosutinib—LYN—Signaling Pathways—CCL2—rheumatoid arthritis	2.55e-07	2.67e-06	CbGpPWpGaD
Bosutinib—EGFR—Immune System—IL1B—rheumatoid arthritis	2.54e-07	2.67e-06	CbGpPWpGaD
Bosutinib—EGFR—Disease—CD4—rheumatoid arthritis	2.54e-07	2.67e-06	CbGpPWpGaD
Bosutinib—LYN—Signaling Pathways—IL6R—rheumatoid arthritis	2.54e-07	2.67e-06	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—B3GNT2—rheumatoid arthritis	2.54e-07	2.66e-06	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—ACP5—rheumatoid arthritis	2.54e-07	2.66e-06	CbGpPWpGaD
Bosutinib—EGFR—Immune System—IL2—rheumatoid arthritis	2.53e-07	2.66e-06	CbGpPWpGaD
Bosutinib—EGFR—Disease—PTGS2—rheumatoid arthritis	2.52e-07	2.65e-06	CbGpPWpGaD
Bosutinib—FYN—Signaling Pathways—CCL2—rheumatoid arthritis	2.51e-07	2.63e-06	CbGpPWpGaD
Bosutinib—FYN—Signaling Pathways—IL6R—rheumatoid arthritis	2.5e-07	2.62e-06	CbGpPWpGaD
Bosutinib—ERBB3—Signaling Pathways—VEGFA—rheumatoid arthritis	2.5e-07	2.62e-06	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling Pathways—CCL2—rheumatoid arthritis	2.49e-07	2.62e-06	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling Pathways—IL6R—rheumatoid arthritis	2.48e-07	2.61e-06	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—SPP1—rheumatoid arthritis	2.48e-07	2.61e-06	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—LEP—rheumatoid arthritis	2.48e-07	2.61e-06	CbGpPWpGaD
Bosutinib—CSNK1E—Signaling Pathways—TP53—rheumatoid arthritis	2.48e-07	2.6e-06	CbGpPWpGaD
Bosutinib—PTK2—Signaling Pathways—MMP9—rheumatoid arthritis	2.48e-07	2.6e-06	CbGpPWpGaD
Bosutinib—ROCK1—Signaling Pathways—TGFB1—rheumatoid arthritis	2.47e-07	2.59e-06	CbGpPWpGaD
Bosutinib—SRC—Developmental Biology—IL6—rheumatoid arthritis	2.47e-07	2.59e-06	CbGpPWpGaD
Bosutinib—ERBB3—Disease—IL6—rheumatoid arthritis	2.47e-07	2.59e-06	CbGpPWpGaD
Bosutinib—LCK—Innate Immune System—IL6—rheumatoid arthritis	2.46e-07	2.58e-06	CbGpPWpGaD
Bosutinib—PTK2—Signaling Pathways—NFKB1—rheumatoid arthritis	2.45e-07	2.57e-06	CbGpPWpGaD
Bosutinib—LCK—Immune System—IL1B—rheumatoid arthritis	2.45e-07	2.57e-06	CbGpPWpGaD
Bosutinib—LCK—Disease—CD4—rheumatoid arthritis	2.45e-07	2.57e-06	CbGpPWpGaD
Bosutinib—IRAK1—Signaling Pathways—IL2—rheumatoid arthritis	2.45e-07	2.57e-06	CbGpPWpGaD
Bosutinib—YES1—Signaling Pathways—MMP9—rheumatoid arthritis	2.44e-07	2.56e-06	CbGpPWpGaD
Bosutinib—LCK—Immune System—IL2—rheumatoid arthritis	2.44e-07	2.56e-06	CbGpPWpGaD
Bosutinib—SRC—Immune System—IFNG—rheumatoid arthritis	2.43e-07	2.55e-06	CbGpPWpGaD
Bosutinib—EGFR—Signaling Pathways—FN1—rheumatoid arthritis	2.43e-07	2.55e-06	CbGpPWpGaD
Bosutinib—LCK—Disease—PTGS2—rheumatoid arthritis	2.43e-07	2.55e-06	CbGpPWpGaD
Bosutinib—EGFR—Signaling Pathways—IL6ST—rheumatoid arthritis	2.42e-07	2.54e-06	CbGpPWpGaD
Bosutinib—MAP2K2—Signaling Pathways—TYK2—rheumatoid arthritis	2.42e-07	2.54e-06	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—CCR5—rheumatoid arthritis	2.42e-07	2.54e-06	CbGpPWpGaD
Bosutinib—YES1—Signaling Pathways—NFKB1—rheumatoid arthritis	2.41e-07	2.54e-06	CbGpPWpGaD
Bosutinib—MAP3K7—Signaling Pathways—CXCL8—rheumatoid arthritis	2.41e-07	2.53e-06	CbGpPWpGaD
Bosutinib—PTK2—Signaling Pathways—MAPK8—rheumatoid arthritis	2.41e-07	2.53e-06	CbGpPWpGaD
Bosutinib—SRC—Disease—TYK2—rheumatoid arthritis	2.39e-07	2.52e-06	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—IL2RA—rheumatoid arthritis	2.38e-07	2.5e-06	CbGpPWpGaD
Bosutinib—RPS6KB1—Signaling Pathways—TGFB1—rheumatoid arthritis	2.38e-07	2.5e-06	CbGpPWpGaD
Bosutinib—MAP2K5—Signaling Pathways—TGFB1—rheumatoid arthritis	2.38e-07	2.5e-06	CbGpPWpGaD
Bosutinib—PTK2—Immune System—IL6—rheumatoid arthritis	2.38e-07	2.5e-06	CbGpPWpGaD
Bosutinib—MAP2K2—Signaling Pathways—NOS3—rheumatoid arthritis	2.37e-07	2.49e-06	CbGpPWpGaD
Bosutinib—YES1—Signaling Pathways—MAPK8—rheumatoid arthritis	2.37e-07	2.49e-06	CbGpPWpGaD
Bosutinib—EGFR—Immune System—NFKB1—rheumatoid arthritis	2.37e-07	2.49e-06	CbGpPWpGaD
Bosutinib—PDGFRB—Signaling Pathways—TYK2—rheumatoid arthritis	2.36e-07	2.48e-06	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—C3—rheumatoid arthritis	2.36e-07	2.48e-06	CbGpPWpGaD
Bosutinib—SRC—Disease—NOS3—rheumatoid arthritis	2.35e-07	2.47e-06	CbGpPWpGaD
Bosutinib—SRC—Immune System—CD4—rheumatoid arthritis	2.35e-07	2.46e-06	CbGpPWpGaD
Bosutinib—YES1—Immune System—IL6—rheumatoid arthritis	2.34e-07	2.46e-06	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—FN1—rheumatoid arthritis	2.34e-07	2.46e-06	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—IL6ST—rheumatoid arthritis	2.33e-07	2.45e-06	CbGpPWpGaD
Bosutinib—EGFR—Immune System—MAPK8—rheumatoid arthritis	2.33e-07	2.45e-06	CbGpPWpGaD
Bosutinib—EGFR—Signaling Pathways—CD80—rheumatoid arthritis	2.33e-07	2.45e-06	CbGpPWpGaD
Bosutinib—PDGFRB—Signaling Pathways—NOS3—rheumatoid arthritis	2.32e-07	2.43e-06	CbGpPWpGaD
Bosutinib—IRAK1—Signaling Pathways—MMP9—rheumatoid arthritis	2.32e-07	2.43e-06	CbGpPWpGaD
Bosutinib—LYN—Signaling Pathways—TYK2—rheumatoid arthritis	2.31e-07	2.43e-06	CbGpPWpGaD
Bosutinib—MAP3K7—Signaling Pathways—IL2—rheumatoid arthritis	2.3e-07	2.42e-06	CbGpPWpGaD
Bosutinib—ERBB3—Signaling Pathways—TGFB1—rheumatoid arthritis	2.29e-07	2.41e-06	CbGpPWpGaD
Bosutinib—IRAK1—Signaling Pathways—NFKB1—rheumatoid arthritis	2.29e-07	2.41e-06	CbGpPWpGaD
Bosutinib—LCK—Immune System—NFKB1—rheumatoid arthritis	2.28e-07	2.4e-06	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—BGN—rheumatoid arthritis	2.28e-07	2.4e-06	CbGpPWpGaD
Bosutinib—FYN—Signaling Pathways—TYK2—rheumatoid arthritis	2.28e-07	2.39e-06	CbGpPWpGaD
Bosutinib—LYN—Signaling Pathways—NOS3—rheumatoid arthritis	2.27e-07	2.38e-06	CbGpPWpGaD
Bosutinib—CSNK1E—Signaling Pathways—IL6—rheumatoid arthritis	2.27e-07	2.38e-06	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling Pathways—TYK2—rheumatoid arthritis	2.26e-07	2.38e-06	CbGpPWpGaD
Bosutinib—IRAK1—Signaling Pathways—MAPK8—rheumatoid arthritis	2.25e-07	2.37e-06	CbGpPWpGaD
Bosutinib—LCK—Immune System—MAPK8—rheumatoid arthritis	2.24e-07	2.36e-06	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—CD80—rheumatoid arthritis	2.24e-07	2.36e-06	CbGpPWpGaD
Bosutinib—MAP2K2—Disease—TGFB1—rheumatoid arthritis	2.24e-07	2.36e-06	CbGpPWpGaD
Bosutinib—FYN—Signaling Pathways—NOS3—rheumatoid arthritis	2.23e-07	2.35e-06	CbGpPWpGaD
Bosutinib—IRAK1—Immune System—IL6—rheumatoid arthritis	2.22e-07	2.34e-06	CbGpPWpGaD
Bosutinib—PTK2—Signaling Pathways—VEGFA—rheumatoid arthritis	2.22e-07	2.33e-06	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling Pathways—NOS3—rheumatoid arthritis	2.22e-07	2.33e-06	CbGpPWpGaD
Bosutinib—EGFR—Signaling Pathways—POMC—rheumatoid arthritis	2.21e-07	2.32e-06	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—LEP—rheumatoid arthritis	2.2e-07	2.31e-06	CbGpPWpGaD
Bosutinib—YES1—Signaling Pathways—VEGFA—rheumatoid arthritis	2.19e-07	2.3e-06	CbGpPWpGaD
Bosutinib—PDGFRB—Disease—TGFB1—rheumatoid arthritis	2.19e-07	2.3e-06	CbGpPWpGaD
Bosutinib—MAP3K7—Signaling Pathways—MMP9—rheumatoid arthritis	2.18e-07	2.29e-06	CbGpPWpGaD
Bosutinib—SRC—Innate Immune System—IL6—rheumatoid arthritis	2.18e-07	2.29e-06	CbGpPWpGaD
Bosutinib—SRC—Immune System—IL1B—rheumatoid arthritis	2.17e-07	2.28e-06	CbGpPWpGaD
Bosutinib—SRC—Disease—CD4—rheumatoid arthritis	2.17e-07	2.27e-06	CbGpPWpGaD
Bosutinib—EGFR—Signaling Pathways—CCL2—rheumatoid arthritis	2.16e-07	2.27e-06	CbGpPWpGaD
Bosutinib—SRC—Immune System—IL2—rheumatoid arthritis	2.16e-07	2.27e-06	CbGpPWpGaD
Bosutinib—EGFR—Signaling Pathways—IL6R—rheumatoid arthritis	2.16e-07	2.27e-06	CbGpPWpGaD
Bosutinib—MAP3K7—Signaling Pathways—NFKB1—rheumatoid arthritis	2.16e-07	2.27e-06	CbGpPWpGaD
Bosutinib—SRC—Disease—PTGS2—rheumatoid arthritis	2.15e-07	2.26e-06	CbGpPWpGaD
Bosutinib—ERBB4—Signaling Pathways—TP53—rheumatoid arthritis	2.14e-07	2.25e-06	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—POMC—rheumatoid arthritis	2.13e-07	2.24e-06	CbGpPWpGaD
Bosutinib—MAP3K7—Signaling Pathways—MAPK8—rheumatoid arthritis	2.12e-07	2.23e-06	CbGpPWpGaD
Bosutinib—PTK2B—Signaling Pathways—TP53—rheumatoid arthritis	2.11e-07	2.22e-06	CbGpPWpGaD
Bosutinib—FYN—Disease—TGFB1—rheumatoid arthritis	2.11e-07	2.22e-06	CbGpPWpGaD
Bosutinib—MAP2K2—Signaling Pathways—CXCL8—rheumatoid arthritis	2.11e-07	2.21e-06	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—ALOX5—rheumatoid arthritis	2.1e-07	2.21e-06	CbGpPWpGaD
Bosutinib—MAP2K1—Disease—TGFB1—rheumatoid arthritis	2.1e-07	2.2e-06	CbGpPWpGaD
Bosutinib—MAP3K7—Immune System—IL6—rheumatoid arthritis	2.09e-07	2.2e-06	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—CCL2—rheumatoid arthritis	2.09e-07	2.19e-06	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—IL6R—rheumatoid arthritis	2.08e-07	2.18e-06	CbGpPWpGaD
Bosutinib—IRAK1—Signaling Pathways—VEGFA—rheumatoid arthritis	2.08e-07	2.18e-06	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—FN1—rheumatoid arthritis	2.07e-07	2.18e-06	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—IL6ST—rheumatoid arthritis	2.06e-07	2.17e-06	CbGpPWpGaD
Bosutinib—PDGFRB—Signaling Pathways—CXCL8—rheumatoid arthritis	2.06e-07	2.16e-06	CbGpPWpGaD
Bosutinib—PTK2—Signaling Pathways—TGFB1—rheumatoid arthritis	2.04e-07	2.14e-06	CbGpPWpGaD
Bosutinib—ROCK1—Signaling Pathways—TP53—rheumatoid arthritis	2.03e-07	2.13e-06	CbGpPWpGaD
Bosutinib—SRC—Immune System—NFKB1—rheumatoid arthritis	2.02e-07	2.12e-06	CbGpPWpGaD
Bosutinib—MAP2K2—Signaling Pathways—IL2—rheumatoid arthritis	2.01e-07	2.11e-06	CbGpPWpGaD
Bosutinib—LYN—Signaling Pathways—CXCL8—rheumatoid arthritis	2.01e-07	2.11e-06	CbGpPWpGaD
Bosutinib—YES1—Signaling Pathways—TGFB1—rheumatoid arthritis	2.01e-07	2.11e-06	CbGpPWpGaD
Bosutinib—MAP2K2—Signaling by GPCR—IL6—rheumatoid arthritis	2e-07	2.1e-06	CbGpPWpGaD
Bosutinib—ABCB1—Metabolism—CAT—rheumatoid arthritis	2e-07	2.1e-06	CbGpPWpGaD
Bosutinib—SRC—Immune System—MAPK8—rheumatoid arthritis	1.99e-07	2.09e-06	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—CD80—rheumatoid arthritis	1.99e-07	2.09e-06	CbGpPWpGaD
Bosutinib—FYN—Signaling Pathways—CXCL8—rheumatoid arthritis	1.98e-07	2.08e-06	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling Pathways—CXCL8—rheumatoid arthritis	1.97e-07	2.07e-06	CbGpPWpGaD
Bosutinib—EGFR—Signaling Pathways—TYK2—rheumatoid arthritis	1.97e-07	2.06e-06	CbGpPWpGaD
Bosutinib—PDGFRB—Signaling Pathways—IL2—rheumatoid arthritis	1.96e-07	2.06e-06	CbGpPWpGaD
Bosutinib—ERBB4—Signaling Pathways—IL6—rheumatoid arthritis	1.96e-07	2.06e-06	CbGpPWpGaD
Bosutinib—MAP3K7—Signaling Pathways—VEGFA—rheumatoid arthritis	1.96e-07	2.06e-06	CbGpPWpGaD
Bosutinib—MAP2K5—Signaling Pathways—TP53—rheumatoid arthritis	1.96e-07	2.06e-06	CbGpPWpGaD
Bosutinib—RPS6KB1—Signaling Pathways—TP53—rheumatoid arthritis	1.96e-07	2.06e-06	CbGpPWpGaD
Bosutinib—PTK2B—Signaling Pathways—IL6—rheumatoid arthritis	1.93e-07	2.03e-06	CbGpPWpGaD
Bosutinib—EGFR—Signaling Pathways—NOS3—rheumatoid arthritis	1.93e-07	2.03e-06	CbGpPWpGaD
Bosutinib—LYN—Signaling Pathways—IL2—rheumatoid arthritis	1.92e-07	2.02e-06	CbGpPWpGaD
Bosutinib—IRAK1—Signaling Pathways—TGFB1—rheumatoid arthritis	1.91e-07	2e-06	CbGpPWpGaD
Bosutinib—MAP2K2—Signaling Pathways—MMP9—rheumatoid arthritis	1.9e-07	2e-06	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—TYK2—rheumatoid arthritis	1.89e-07	1.99e-06	CbGpPWpGaD
Bosutinib—FYN—Signaling Pathways—IL2—rheumatoid arthritis	1.89e-07	1.99e-06	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—POMC—rheumatoid arthritis	1.89e-07	1.98e-06	CbGpPWpGaD
Bosutinib—ERBB3—Signaling Pathways—TP53—rheumatoid arthritis	1.89e-07	1.98e-06	CbGpPWpGaD
Bosutinib—MAP2K2—Signaling Pathways—NFKB1—rheumatoid arthritis	1.88e-07	1.98e-06	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling Pathways—IL2—rheumatoid arthritis	1.88e-07	1.98e-06	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling by GPCR—IL6—rheumatoid arthritis	1.87e-07	1.97e-06	CbGpPWpGaD
Bosutinib—ROCK1—Signaling Pathways—IL6—rheumatoid arthritis	1.86e-07	1.95e-06	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—NOS3—rheumatoid arthritis	1.86e-07	1.95e-06	CbGpPWpGaD
Bosutinib—PDGFRB—Signaling Pathways—MMP9—rheumatoid arthritis	1.86e-07	1.95e-06	CbGpPWpGaD
Bosutinib—MAP2K2—Signaling Pathways—MAPK8—rheumatoid arthritis	1.85e-07	1.95e-06	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—CCL2—rheumatoid arthritis	1.85e-07	1.94e-06	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—IL6R—rheumatoid arthritis	1.84e-07	1.93e-06	CbGpPWpGaD
Bosutinib—PDGFRB—Signaling Pathways—NFKB1—rheumatoid arthritis	1.84e-07	1.93e-06	CbGpPWpGaD
Bosutinib—MAP2K2—Immune System—IL6—rheumatoid arthritis	1.83e-07	1.92e-06	CbGpPWpGaD
Bosutinib—EGFR—Disease—TGFB1—rheumatoid arthritis	1.82e-07	1.91e-06	CbGpPWpGaD
Bosutinib—LYN—Signaling Pathways—MMP9—rheumatoid arthritis	1.82e-07	1.91e-06	CbGpPWpGaD
Bosutinib—PDGFRB—Signaling Pathways—MAPK8—rheumatoid arthritis	1.81e-07	1.9e-06	CbGpPWpGaD
Bosutinib—LYN—Signaling Pathways—NFKB1—rheumatoid arthritis	1.8e-07	1.89e-06	CbGpPWpGaD
Bosutinib—MAP3K7—Signaling Pathways—TGFB1—rheumatoid arthritis	1.8e-07	1.89e-06	CbGpPWpGaD
Bosutinib—FYN—Signaling Pathways—MMP9—rheumatoid arthritis	1.79e-07	1.88e-06	CbGpPWpGaD
Bosutinib—RPS6KB1—Signaling Pathways—IL6—rheumatoid arthritis	1.79e-07	1.88e-06	CbGpPWpGaD
Bosutinib—MAP2K5—Signaling Pathways—IL6—rheumatoid arthritis	1.79e-07	1.88e-06	CbGpPWpGaD
Bosutinib—PDGFRB—Immune System—IL6—rheumatoid arthritis	1.79e-07	1.88e-06	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling Pathways—MMP9—rheumatoid arthritis	1.78e-07	1.87e-06	CbGpPWpGaD
Bosutinib—FYN—Signaling Pathways—NFKB1—rheumatoid arthritis	1.77e-07	1.86e-06	CbGpPWpGaD
Bosutinib—LYN—Signaling Pathways—MAPK8—rheumatoid arthritis	1.77e-07	1.86e-06	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling Pathways—NFKB1—rheumatoid arthritis	1.76e-07	1.85e-06	CbGpPWpGaD
Bosutinib—LCK—Disease—TGFB1—rheumatoid arthritis	1.76e-07	1.84e-06	CbGpPWpGaD
Bosutinib—LYN—Immune System—IL6—rheumatoid arthritis	1.75e-07	1.84e-06	CbGpPWpGaD
Bosutinib—FYN—Signaling Pathways—MAPK8—rheumatoid arthritis	1.74e-07	1.83e-06	CbGpPWpGaD
Bosutinib—ABL1—Immune System—IL6—rheumatoid arthritis	1.74e-07	1.83e-06	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling Pathways—MAPK8—rheumatoid arthritis	1.73e-07	1.82e-06	CbGpPWpGaD
Bosutinib—ERBB3—Signaling Pathways—IL6—rheumatoid arthritis	1.73e-07	1.81e-06	CbGpPWpGaD
Bosutinib—FYN—Immune System—IL6—rheumatoid arthritis	1.72e-07	1.81e-06	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—ENO1—rheumatoid arthritis	1.71e-07	1.8e-06	CbGpPWpGaD
Bosutinib—MAP2K1—Immune System—IL6—rheumatoid arthritis	1.71e-07	1.8e-06	CbGpPWpGaD
Bosutinib—EGFR—Signaling Pathways—CXCL8—rheumatoid arthritis	1.71e-07	1.8e-06	CbGpPWpGaD
Bosutinib—MAP2K2—Signaling Pathways—VEGFA—rheumatoid arthritis	1.71e-07	1.8e-06	CbGpPWpGaD
Bosutinib—MAP2K2—Disease—IL6—rheumatoid arthritis	1.69e-07	1.77e-06	CbGpPWpGaD
Bosutinib—PTK2—Signaling Pathways—TP53—rheumatoid arthritis	1.68e-07	1.76e-06	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—TYK2—rheumatoid arthritis	1.68e-07	1.76e-06	CbGpPWpGaD
Bosutinib—ABCB1—Metabolism—MTHFR—rheumatoid arthritis	1.67e-07	1.75e-06	CbGpPWpGaD
Bosutinib—PDGFRB—Signaling Pathways—VEGFA—rheumatoid arthritis	1.67e-07	1.75e-06	CbGpPWpGaD
Bosutinib—YES1—Signaling Pathways—TP53—rheumatoid arthritis	1.66e-07	1.74e-06	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—CXCL8—rheumatoid arthritis	1.65e-07	1.73e-06	CbGpPWpGaD
Bosutinib—PDGFRB—Disease—IL6—rheumatoid arthritis	1.65e-07	1.73e-06	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—NOS3—rheumatoid arthritis	1.65e-07	1.73e-06	CbGpPWpGaD
Bosutinib—EGFR—Signaling Pathways—IL2—rheumatoid arthritis	1.64e-07	1.72e-06	CbGpPWpGaD
Bosutinib—LYN—Signaling Pathways—VEGFA—rheumatoid arthritis	1.63e-07	1.72e-06	CbGpPWpGaD
Bosutinib—EGFR—Signaling by GPCR—IL6—rheumatoid arthritis	1.63e-07	1.71e-06	CbGpPWpGaD
Bosutinib—FYN—Signaling Pathways—VEGFA—rheumatoid arthritis	1.61e-07	1.69e-06	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling Pathways—VEGFA—rheumatoid arthritis	1.6e-07	1.68e-06	CbGpPWpGaD
Bosutinib—FYN—Disease—IL6—rheumatoid arthritis	1.59e-07	1.67e-06	CbGpPWpGaD
Bosutinib—MAP2K1—Disease—IL6—rheumatoid arthritis	1.58e-07	1.66e-06	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—IL2—rheumatoid arthritis	1.58e-07	1.66e-06	CbGpPWpGaD
Bosutinib—IRAK1—Signaling Pathways—TP53—rheumatoid arthritis	1.57e-07	1.65e-06	CbGpPWpGaD
Bosutinib—MAP2K2—Signaling Pathways—TGFB1—rheumatoid arthritis	1.57e-07	1.65e-06	CbGpPWpGaD
Bosutinib—SRC—Disease—TGFB1—rheumatoid arthritis	1.55e-07	1.63e-06	CbGpPWpGaD
Bosutinib—EGFR—Signaling Pathways—MMP9—rheumatoid arthritis	1.55e-07	1.63e-06	CbGpPWpGaD
Bosutinib—PTK2—Signaling Pathways—IL6—rheumatoid arthritis	1.54e-07	1.61e-06	CbGpPWpGaD
Bosutinib—PDGFRB—Signaling Pathways—TGFB1—rheumatoid arthritis	1.53e-07	1.61e-06	CbGpPWpGaD
Bosutinib—EGFR—Signaling Pathways—NFKB1—rheumatoid arthritis	1.53e-07	1.61e-06	CbGpPWpGaD
Bosutinib—YES1—Signaling Pathways—IL6—rheumatoid arthritis	1.52e-07	1.59e-06	CbGpPWpGaD
Bosutinib—EGFR—Signaling Pathways—MAPK8—rheumatoid arthritis	1.51e-07	1.58e-06	CbGpPWpGaD
Bosutinib—LYN—Signaling Pathways—TGFB1—rheumatoid arthritis	1.5e-07	1.58e-06	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—MMP9—rheumatoid arthritis	1.49e-07	1.57e-06	CbGpPWpGaD
Bosutinib—EGFR—Immune System—IL6—rheumatoid arthritis	1.49e-07	1.56e-06	CbGpPWpGaD
Bosutinib—MAP3K7—Signaling Pathways—TP53—rheumatoid arthritis	1.48e-07	1.55e-06	CbGpPWpGaD
Bosutinib—FYN—Signaling Pathways—TGFB1—rheumatoid arthritis	1.48e-07	1.55e-06	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—NFKB1—rheumatoid arthritis	1.48e-07	1.55e-06	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling Pathways—TGFB1—rheumatoid arthritis	1.47e-07	1.54e-06	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—CXCL8—rheumatoid arthritis	1.46e-07	1.53e-06	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—MAPK8—rheumatoid arthritis	1.45e-07	1.52e-06	CbGpPWpGaD
Bosutinib—IRAK1—Signaling Pathways—IL6—rheumatoid arthritis	1.44e-07	1.51e-06	CbGpPWpGaD
Bosutinib—LCK—Immune System—IL6—rheumatoid arthritis	1.43e-07	1.51e-06	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—IL2—rheumatoid arthritis	1.4e-07	1.47e-06	CbGpPWpGaD
Bosutinib—EGFR—Signaling Pathways—VEGFA—rheumatoid arthritis	1.39e-07	1.46e-06	CbGpPWpGaD
Bosutinib—EGFR—Disease—IL6—rheumatoid arthritis	1.37e-07	1.44e-06	CbGpPWpGaD
Bosutinib—MAP3K7—Signaling Pathways—IL6—rheumatoid arthritis	1.35e-07	1.42e-06	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—VEGFA—rheumatoid arthritis	1.34e-07	1.41e-06	CbGpPWpGaD
Bosutinib—ABCB1—Metabolism—POMC—rheumatoid arthritis	1.34e-07	1.4e-06	CbGpPWpGaD
Bosutinib—LCK—Disease—IL6—rheumatoid arthritis	1.32e-07	1.39e-06	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—MMP9—rheumatoid arthritis	1.32e-07	1.39e-06	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—NFKB1—rheumatoid arthritis	1.31e-07	1.37e-06	CbGpPWpGaD
Bosutinib—MAP2K2—Signaling Pathways—TP53—rheumatoid arthritis	1.29e-07	1.36e-06	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—MAPK8—rheumatoid arthritis	1.28e-07	1.35e-06	CbGpPWpGaD
Bosutinib—EGFR—Signaling Pathways—TGFB1—rheumatoid arthritis	1.28e-07	1.34e-06	CbGpPWpGaD
Bosutinib—SRC—Immune System—IL6—rheumatoid arthritis	1.27e-07	1.33e-06	CbGpPWpGaD
Bosutinib—PDGFRB—Signaling Pathways—TP53—rheumatoid arthritis	1.26e-07	1.32e-06	CbGpPWpGaD
Bosutinib—LYN—Signaling Pathways—TP53—rheumatoid arthritis	1.23e-07	1.3e-06	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—CAT—rheumatoid arthritis	1.23e-07	1.29e-06	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—TGFB1—rheumatoid arthritis	1.23e-07	1.29e-06	CbGpPWpGaD
Bosutinib—ABCB1—Metabolism—ALB—rheumatoid arthritis	1.22e-07	1.28e-06	CbGpPWpGaD
Bosutinib—FYN—Signaling Pathways—TP53—rheumatoid arthritis	1.22e-07	1.28e-06	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling Pathways—TP53—rheumatoid arthritis	1.21e-07	1.27e-06	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—VEGFA—rheumatoid arthritis	1.19e-07	1.25e-06	CbGpPWpGaD
Bosutinib—MAP2K2—Signaling Pathways—IL6—rheumatoid arthritis	1.18e-07	1.24e-06	CbGpPWpGaD
Bosutinib—SRC—Disease—IL6—rheumatoid arthritis	1.17e-07	1.23e-06	CbGpPWpGaD
Bosutinib—ABCB1—Metabolism—NOS3—rheumatoid arthritis	1.16e-07	1.22e-06	CbGpPWpGaD
Bosutinib—PDGFRB—Signaling Pathways—IL6—rheumatoid arthritis	1.15e-07	1.21e-06	CbGpPWpGaD
Bosutinib—LYN—Signaling Pathways—IL6—rheumatoid arthritis	1.13e-07	1.19e-06	CbGpPWpGaD
Bosutinib—FYN—Signaling Pathways—IL6—rheumatoid arthritis	1.11e-07	1.17e-06	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling Pathways—IL6—rheumatoid arthritis	1.11e-07	1.16e-06	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—TGFB1—rheumatoid arthritis	1.09e-07	1.14e-06	CbGpPWpGaD
Bosutinib—ABCB1—Metabolism—PTGS2—rheumatoid arthritis	1.07e-07	1.12e-06	CbGpPWpGaD
Bosutinib—EGFR—Signaling Pathways—TP53—rheumatoid arthritis	1.05e-07	1.1e-06	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—MTHFR—rheumatoid arthritis	1.03e-07	1.08e-06	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—TP53—rheumatoid arthritis	1.01e-07	1.06e-06	CbGpPWpGaD
Bosutinib—EGFR—Signaling Pathways—IL6—rheumatoid arthritis	9.61e-08	1.01e-06	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—IL6—rheumatoid arthritis	9.26e-08	9.73e-07	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—TP53—rheumatoid arthritis	8.96e-08	9.41e-07	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—POMC—rheumatoid arthritis	8.23e-08	8.64e-07	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—IL6—rheumatoid arthritis	8.2e-08	8.62e-07	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—ALB—rheumatoid arthritis	7.5e-08	7.88e-07	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—NOS3—rheumatoid arthritis	7.18e-08	7.54e-07	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—PTGS2—rheumatoid arthritis	6.56e-08	6.89e-07	CbGpPWpGaD
